[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360089-105":59,"doc-detail-360089-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","systemic-administration-of-liposomal-trehalose-dimycolate-induces-nk11-cell-mediated-antitumor-immunity-in-bladder-cancer","Systemic administration of liposomal trehalose dimycolate induces NK1.1+ cell mediated antitumor immunity in bladder cancer","","Intravesical Bacillus Calmette-Guerin (BCG) is the most effective bladder cancer immunotherapy, yet live bacteria can trigger serious adverse events and are confined to local administration. The study reports trehalose 6,6′-dimycolate (TDM) as a less toxic, adjuvant-acting component within hydrophilic cationic liposomes. While Lip-TDM previously showed local antitumor effects, intraperitoneal dosing produced systemic immunity and reduced tumor incidence, via dendritic cells, macrophages, CD8+ T-cell infiltration, and NK1.1+ lymphocyte-dependent cytotoxicity.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/systemic-administration-of-liposomal-trehalose-dimycolate-induces-nk11-cell-mediated-antitumor-immunity-in-bladder-cancer/360089/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/systemic-administration-of-liposomal-trehalose-dimycolate-induces-nk11-cell-mediated-antitumor-immunity-in-bladder-cancer/360089.png","ImageObject",300,407,{"name":92,"@type":93},"Putri","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why does the study focus on trehalose 6,6′-dimycolate (TDM) instead of using live BCG systemically?","Question",{"text":112,"@type":113},"Live BCG can cause serious, even fatal infections and is limited to direct tumor-site administration. TDM is described as a predominant BCG cell wall glycolipid with a potent adjuvant effect, and liposomal delivery is used to improve its properties and toxicity profile.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What antitumor effect does Lip-TDM show beyond local administration?",{"text":117,"@type":113},"Intraperitoneal administration of Lip-TDM enhances systemic activation of dendritic cells and macrophages, increases infiltration of CD8+ T cells, and reduces bladder cancer incidence compared with a control treatment group.",{"name":119,"@type":110,"acceptedAnswer":120},"What immune cell type is essential for Lip-TDM to induce the acquired anti-tumor response?",{"text":121,"@type":113},"NK1.1+ lymphocytes are highlighted as essential. The antitumor effect is observed in wild-type mice but not in NK cell-depleted mice, indicating a required role for NK cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},360089,1790211728,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085571259,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Tanuma etal. BMC Cancer (2026) 26:610 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15951-1](https://doi.org/10.1186/s12885-026-15951-1)  \nRESEARCH Open Access  \nSystemic administration of liposomal trehalose dimycolate induces NK1.1 ⁺ cell mediated antitumor immunity in bladder cancer  \nKozaburoTanuma1, Masanobu Shiga1, Keisuke Sano1, Kazuki Hamada 1, Satoshi Nitta 1, Ichiro Chihara1, Yoshiyuki Nagumo 1, Shuya Kandori 1, Akio Hoshi1, Hiromitsu Negoro 1, Bryan J. Mathis2, Jun Miyazaki3* and Hiroyuki Nishiyama 1  \nAbstract  \nIntravesical Bacillus Calmette-Guerin (BCG) administration is the most effective immunotherapy for bladder cancer, but live BCG bacteria may cause serious adverse events and are limited to local administration. Here, we report the formulation of a less toxic treatment using trehalose 6,6′-dimycolate (TDM), a predominant BCG cell wall glycolipid, that activates innate immunity and carries an adjuvant effect. We previously established hydrophilic cationic liposomes incorporating TDM (Lip-TDM) and found that local administration of Lip-TDM exerts antitumor effects on subcutaneously inoculated tumors by inducing CD8+ T cell activation via dendritic cell maturation. Here, we further demonstrate that intraperitoneal administration of Lip-TDM exerts antitumor effects in an N-butyl-N-(4-hydroxybutyl) nitrosamine-induced, orthotopic bladder carcinogenesis mouse model. The incidence of bladder cancer in the Lip-TDM treated group was significantly lower compared to the Lip-CON treated group (60 . 8%[14 out of 23] versus 95.4%[21 out of 22], p \u003C 0. 01) . Intraperitoneal administration of Lip-TDM enhanced the systemic activation of dendric cells and macrophages, increasing infiltration of CD8+ T cells. Furthermore, Lip-TDM treatment induced both natural killer (NK) cell cytotoxic activity against tumors while enriching regulatory NK populations in lymphoid tissues. This antitumor effect was seen in WT mice but not NK cell-depleted mice. These results highlight NK1 .1⁺ lymphocytes as essential for Lip-TDM to induce the acquired immune anti-tumor response. Our findings suggest that Lip-TDM is a non-infectious, NK-activating, anti-tumor agent which can be administered intraperitoneally or systemically as a potential alternative to BCG.  \nKeywords Trehalose dimycolate, BCG, Bladder cancer, Liposome, Natural killer cell  \n*Correspondence: Jun Miyazaki [jmiyazaki@iuhw.ac.jp](jmiyazaki@iuhw.ac.jp)  \n1Department of Urology, University of Tsukuba, Tsukuba, Japan 2Department of Cardiovascular Surgery, University of Tsukuba, Tsukuba, Japan  \n3Department of Urology, School of Medicine, International University of Health and Welfare, 852 Hatakeda, Narita, Chiba 286-0124, Japan  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nTanuma et al. BMC Cancer (2026) 26:610  \nIntroduction  \nUrothelial carcinomas, including bladder cancer, are characterized by a t","cbCailgmljo4vQ8m","https://ap.wps.com/l/cbCailgmljo4vQ8m","pdf",7684374,14,"English","# Abstract\n# Introduction\n## Background on bladder cancer immunotherapy\n## Limitations of BCG and need for alternatives\n## Role of TDM and liposomal formulation","[{\"question\":\"Why does the study focus on trehalose 6,6′-dimycolate (TDM) instead of using live BCG systemically?\",\"answer\":\"Live BCG can cause serious, even fatal infections and is limited to direct tumor-site administration. TDM is described as a predominant BCG cell wall glycolipid with a potent adjuvant effect, and liposomal delivery is used to improve its properties and toxicity profile.\"},{\"question\":\"What antitumor effect does Lip-TDM show beyond local administration?\",\"answer\":\"Intraperitoneal administration of Lip-TDM enhances systemic activation of dendritic cells and macrophages, increases infiltration of CD8+ T cells, and reduces bladder cancer incidence compared with a control treatment group.\"},{\"question\":\"What immune cell type is essential for Lip-TDM to induce the acquired anti-tumor response?\",\"answer\":\"NK1.1+ lymphocytes are highlighted as essential. The antitumor effect is observed in wild-type mice but not in NK cell-depleted mice, indicating a required role for NK cells.\"}]","Systemic administration of liposomal trehalose dimycolate induces NK1.1+ cell mediated antitumor immunity in bladder cancer | PDF",1790138724,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0f3636dcc5bb32c199f2af17c3827fe0.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8f62b06fc978f5cd08810e87914e2fa.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f1be9637231d91fb048262541d21d547.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/87a3d57fdd93ed890861840273257b60.webp",980,1306]